A detailed history of Ranger Investment Management, L.P. transactions in Repligen Corp stock. As of the latest transaction made, Ranger Investment Management, L.P. holds 230,391 shares of RGEN stock, worth $28.7 Million. This represents 2.26% of its overall portfolio holdings.

Number of Shares
230,391
Previous 221,366 4.08%
Holding current value
$28.7 Million
Previous $27.9 Million 22.87%
% of portfolio
2.26%
Previous 1.95%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$119.79 - $167.35 $1.08 Million - $1.51 Million
9,025 Added 4.08%
230,391 $34.3 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $6.21 Million - $9.47 Million
51,790 Added 30.54%
221,366 $27.9 Million
Q1 2024

May 15, 2024

SELL
$170.78 - $208.42 $724,277 - $883,909
-4,241 Reduced 2.44%
169,576 $31.2 Million
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $83,686 - $135,861
733 Added 0.42%
173,817 $31.3 Million
Q3 2023

Nov 14, 2023

SELL
$138.78 - $176.51 $874,036 - $1.11 Million
-6,298 Reduced 3.51%
173,084 $27.5 Million
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $3.97 Million - $5.17 Million
-28,656 Reduced 13.77%
179,382 $25.4 Million
Q1 2023

May 05, 2023

BUY
$154.26 - $198.1 $2.08 Million - $2.67 Million
13,497 Added 6.94%
208,038 $35 Million
Q4 2022

Feb 14, 2023

BUY
$162.42 - $220.56 $909,064 - $1.23 Million
5,597 Added 2.96%
194,541 $32.9 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $5.82 Million - $9.3 Million
-36,303 Reduced 16.12%
188,944 $35.4 Million
Q2 2022

Aug 15, 2022

BUY
$140.68 - $188.02 $6.38 Million - $8.53 Million
45,370 Added 25.22%
225,247 $36.6 Million
Q1 2022

May 13, 2022

BUY
$161.19 - $257.96 $757,270 - $1.21 Million
4,698 Added 2.68%
179,877 $33.8 Million
Q4 2021

Feb 11, 2022

SELL
$247.59 - $304.47 $3.11 Million - $3.82 Million
-12,544 Reduced 6.68%
175,179 $46.4 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $21.9 Million - $36.5 Million
-112,668 Reduced 37.51%
187,723 $54.3 Million
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $1.16 Million - $1.55 Million
-7,008 Reduced 2.28%
300,391 $60 Million
Q1 2021

May 17, 2021

SELL
$180.37 - $226.26 $5.84 Million - $7.32 Million
-32,372 Reduced 9.53%
307,399 $59.8 Million
Q4 2020

Feb 12, 2021

SELL
$148.08 - $206.57 $3.87 Million - $5.39 Million
-26,113 Reduced 7.14%
339,771 $65.1 Million
Q3 2020

Nov 16, 2020

SELL
$122.51 - $158.27 $5.91 Million - $7.64 Million
-48,277 Reduced 11.66%
365,884 $54 Million
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $5.33 Million - $7.94 Million
-56,548 Reduced 12.01%
414,161 $51.2 Million
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $4.3 Million - $5.52 Million
-50,622 Reduced 9.71%
470,709 $45.4 Million
Q4 2019

Feb 14, 2020

BUY
$73.84 - $93.08 $6.45 Million - $8.13 Million
87,300 Added 20.11%
521,331 $48.2 Million
Q3 2019

Nov 14, 2019

SELL
$76.65 - $95.51 $6.94 Million - $8.65 Million
-90,520 Reduced 17.26%
434,031 $33.3 Million
Q2 2019

Aug 14, 2019

SELL
$54.2 - $85.95 $298,371 - $473,154
-5,505 Reduced 1.04%
524,551 $45.1 Million
Q1 2019

May 15, 2019

SELL
$49.45 - $62.8 $4.33 Million - $5.5 Million
-87,605 Reduced 14.18%
530,056 $31.3 Million
Q4 2018

Feb 14, 2019

SELL
$48.26 - $68.88 $465,709 - $664,692
-9,650 Reduced 1.54%
617,661 $32.6 Million
Q3 2018

Nov 14, 2018

SELL
$46.8 - $58.97 $10.4 Million - $13.1 Million
-221,678 Reduced 26.11%
627,311 $34.8 Million
Q2 2018

Aug 14, 2018

BUY
$35.26 - $47.04 $5.56 Million - $7.41 Million
157,567 Added 22.79%
848,989 $39.9 Million
Q1 2018

May 15, 2018

SELL
$30.92 - $37.27 $284,154 - $342,511
-9,190 Reduced 1.31%
691,422 $25 Million
Q4 2017

Feb 13, 2018

SELL
$32.53 - $38.92 $1.09 Million - $1.31 Million
-33,620 Reduced 4.58%
700,612 $25.4 Million
Q3 2017

Nov 14, 2017

BUY
$36.98 - $46.06 $27.2 Million - $33.8 Million
734,232
734,232 $28.1 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Ranger Investment Management, L.P. Portfolio

Follow Ranger Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranger Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ranger Investment Management, L.P. with notifications on news.